What's breaking now, across thousands of outlets.
As the European Union reconsiders pesticide safeguards, South Africa has a crucial window to reform its nearly 80-year-old regulatory framework and protect public health and children's development.
We haven't written up this one. Mail and Guardian has the full story — the link below goes straight to it.
Thousands of people visit emergency departments with headaches every year, but research suggests the way these visits are recorded may be hiding important clues about patients' needs.
The French biotech Axoltis Pharma reported a Phase 2 failure in ALS on Tuesday morning, but suggested it found a small signal to move the drug forward amid a noisy dataset.
Smoking cannabis is now permitted for adults with many restrictions. At the same time, the market for cannabis as a medicine is growing strongly. The new minister wants to put a stop to this.
The FDA’s long-awaited expedited investigational new drug pilot program began accepting applications Tuesday, with top agency officials incorporating public feedback into who should qualify.
Repeat SARS-C0V-2 infections were linked to a higher odds of new health conditions, according to a new study in the Canada Communicable Disease Report.
